GSK Investigational Site

Ciudad de Buenos Aires C1118AAT

1 studies enrolling now · 6 studies all time

What they study most

Hypertension, Pulmonary, Neoplasms, Neoplasms, Breast, Prostatic Hyperplasia, Sepsis, Solid Tumors

Studies at this site

• A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1) — Recruiting now
• Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease — Running, not enrolling
• Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529 — Completed
• Efficacy and Safety of Ambrisentan in Children 8-18yrs — Stopped early
• GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults — Completed
• Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment — Completed